These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 34490171)
1. The Efficacy and Safety of Rituximab for Childhood Steroid-Dependent Nephrotic Syndrome: A Systematic Review and Meta-Analysis. Liu S; Gui C; Lu Z; Li H; Fu Z; Deng Y Front Pediatr; 2021; 9():728010. PubMed ID: 34490171 [No Abstract] [Full Text] [Related]
2. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07). Horinouchi T; Sako M; Nakanishi K; Ishikura K; Ito S; Nakamura H; Oba MS; Nozu K; Iijima K BMC Nephrol; 2018 Nov; 19(1):302. PubMed ID: 30382824 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of rituximab for childhood refractory nephrotic syndrome: A meta-analysis of randomized controlled trials. Chang D; Gong M; Liu C; Zhang Q; Hu Z; Li Z Med Clin (Barc); 2021 Nov; 157(9):418-426. PubMed ID: 33070945 [TBL] [Abstract][Full Text] [Related]
4. Rituximab therapy in adults with steroid-dependent nephrotic syndrome. Zhong H; Li HY; Zhou T; Weng W Arch Med Sci; 2023; 19(3):577-585. PubMed ID: 37313189 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of rituximab in the treatment of membranous nephropathy: A systematic review and meta-analysis. Lu W; Gong S; Li J; Luo H; Wang Y Medicine (Baltimore); 2020 Apr; 99(16):e19804. PubMed ID: 32311997 [TBL] [Abstract][Full Text] [Related]
6. Rituximab in children with steroid-dependent nephrotic syndrome: experience of a tertiary center and review of the literature. Van Horebeek I; Knops N; Van Dyck M; Levtchenko E; Mekahli D Acta Clin Belg; 2017 Jun; 72(3):147-155. PubMed ID: 27409338 [TBL] [Abstract][Full Text] [Related]
7. Predictive factors of long-term disease remission after rituximab administration in patients with childhood-onset complicated steroid-dependent nephrotic syndrome: a single-center retrospective study. Ohyama R; Fujinaga S; Sakuraya K; Hirano D; Ito S Clin Exp Nephrol; 2023 Oct; 27(10):865-872. PubMed ID: 37477752 [TBL] [Abstract][Full Text] [Related]
8. [Efficacy and safety of low-dose rituximab in treatment of pediatric nephrotic syndrome: a prospective randomized controlled trial]. Zhu Y; Wu L; Wang Y; Zhu YF; Peng Y; Fang SH; Zhang LD; Deng F Zhongguo Dang Dai Er Ke Za Zhi; 2023 Jun; 25(6):606-611. PubMed ID: 37382130 [TBL] [Abstract][Full Text] [Related]
9. Long-term repeated rituximab treatment for childhood steroid-dependent nephrotic syndrome. Kim JH; Park E; Hyun HS; Cho MH; Ahn YH; Choi HJ; Kang HG; Ha IS; Cheong HI Kidney Res Clin Pract; 2017 Sep; 36(3):257-263. PubMed ID: 28904877 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of rituximab therapy in children with refractory nephrotic syndrome: a prospective observational study in Shanghai. Sun L; Xu H; Shen Q; Cao Q; Rao J; Liu HM; Fang XY; Zhou LJ World J Pediatr; 2014 Feb; 10(1):59-63. PubMed ID: 24464665 [TBL] [Abstract][Full Text] [Related]
11. Survey of rituximab treatment for childhood-onset refractory nephrotic syndrome. Ito S; Kamei K; Ogura M; Udagawa T; Fujinaga S; Saito M; Sako M; Iijima K Pediatr Nephrol; 2013 Feb; 28(2):257-64. PubMed ID: 23052656 [TBL] [Abstract][Full Text] [Related]
12. Systematic Review and Meta-Analysis of Rituximab for Steroid-Dependent or Frequently Relapsing Nephrotic Syndrome in Children. Gao X; Wang Y; Xu Z; Deng H; Yang H; Zhong F Front Pediatr; 2021; 9():626323. PubMed ID: 34368023 [No Abstract] [Full Text] [Related]
13. Efficacy of rituximab therapy in children with nephrotic syndrome: a 10-year experience from an Iranian pediatric hospital. Bazargani B; Noparast Z; Khedmat L; Fahimi D; Esfahani ST; Moghtaderi M; Abbasi A; Afshin A; Mojtahedi SY BMC Pediatr; 2022 Jan; 22(1):36. PubMed ID: 35022016 [TBL] [Abstract][Full Text] [Related]
14. Single dose of rituximab in children with steroid-dependent minimal change nephrotic syndrome. Niu XL; Hao S; Wang P; Zhang W; Guo GM; Wu Y; Kuang XY; Zhu GH; Huang WY Biomed Rep; 2016 Aug; 5(2):237-242. PubMed ID: 27446549 [TBL] [Abstract][Full Text] [Related]
15. [Incidence of hypogammaglobulinaemia in children with steroid-dependent/frequently relapsing nephrotic syndrome treated with rituximab and its association with severe infections]. Zhi YZ; Cao L; Ying DJ; Dou WJ; Gu R; Zhang JJ Zhonghua Yi Xue Za Zhi; 2024 Feb; 104(6):433-439. PubMed ID: 38326055 [No Abstract] [Full Text] [Related]
16. Study protocol: multicenter double-blind, randomized, placebo-controlled trial of rituximab for the treatment of childhood-onset early-stage uncomplicated frequently relapsing or steroid-dependent nephrotic syndrome (JSKDC10 trial). Nagano C; Sako M; Kamei K; Ishikura K; Nakamura H; Nakanishi K; Omori T; Nozu K; Iijima K BMC Nephrol; 2019 Aug; 20(1):293. PubMed ID: 31375087 [TBL] [Abstract][Full Text] [Related]
17. Maintenance therapy with mycophenolate mofetil after rituximab in pediatric patients with steroid-dependent nephrotic syndrome. Ito S; Kamei K; Ogura M; Sato M; Fujimaru T; Ishikawa T; Udagawa T; Iijima K Pediatr Nephrol; 2011 Oct; 26(10):1823-8. PubMed ID: 21556716 [TBL] [Abstract][Full Text] [Related]